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ABSTRACT 
Objective: The present study was designed to develop a mucoadhesive tablet of pentoxifylline using the mucoadhesive natural polymer from the 
plant Manilkara zapota Linn.  
Methods: The tablets were formulated with three different concentrations of the isolated polymer and evaluated for thickness, weight variation, 
friability, hardness, swelling index, mucoadhesive strength and in vitro drug release. The swelling index was indirectly proportional to the 
mucoadhesive polymer of Manilkara zapota (MAPMZ) concentration.  
Results: The tablets formulated with a high concentration of MAPMZ showed good mucoadhesion strength in 5 min contact time. The in vitro drug 
release studies indicated that the drug release was directly proportional to MAPMZ concentration. The release kinetics indicated that the drug 
release was followed the zero-order. 
Conclusion: The MAPMZ showed the controlled release of pentoxifylline for a period of 12 h. 
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Mucoadhesive drug delivery system has recently gained more interest in 
pharma profession [1]. Mucoadhesion is a facet of bioadhesion that is 
aimed to localize the drugs at a certain mucosal area in the body. Water-
soluble polymers, those become adhesive on hydration, has been used to 
design the formulation. The most important aims of mucoadhesion are 
drug targeting, sustained/controlled release, increasing of gastric 
residence time, minimizing the first pass effect and reducing the adverse 
effects [2, 3]. The polymers chosen for mucoadhesion must be non-
absorbable, non-toxic, biocompatible, non-covalent adhesive and 
economic [4]. These polymers may be either natural (sodium alginate, 
gelatin and guar gum) or synthetic/semi-synthetic (sodium 
carboxymethyl cellulose, carbopol 934 and hydroxypropyl 
methylcellulose) [5–9]. They may be used either alone or blends of two 
or more adhesive polymers for mucoadhesive systems. 
Manilkara zapota Linn. (M. zapota), is an evergreen plant belongs to the 
family Sapotaceae, grows up to 8-15 m height. It is cultivated throughout 
Indian subcontinent including Bangladesh, though it is native to Mexico 
and Central America. The seeds of M. zapota are diuretic tonic aperients 
and febrifuge. Stem bark is act as an astringent, febrifuge [10] and 
anticancer [11]. The leaves and bark are used to treat cough, cold, 
dysentery and diarrhea [12]. Antimicrobial and antioxidant activities are 
also reported from the leaves of M. zapota [13, 14]. A natural gum from 
the seeds of the plant was also isolated [15]. 
Even though many advances have been made in the area of 
mucoadhesives, still many challenges ahead in this area and also the 
search for newer mucoadhesives are going on. The objective of this 
study was to develop mucoadhesive tablets of pentoxifylline using 
the mucoadhesive polymer from the plant Manilkara Zapota Linn. 
(MAPMZ) with respect to the in vitro drug release rate and the 
characterization of the isolated polymer. 
MATERIALS AND METHODS 
Materials 
The seeds of Manilkara zapota were purchased from the local vendors of 
Chennai, Tamilnadu in the month of December 2017. The collected seeds 
were identified and authenticated by a botanist Dr. S. Balasubramanian, 
ABS Medicinal garden, Salem. The voucher specimen (MZG-1) was kept 
in our museum for future reference. Pentoxifylline was obtained as a gift 
sample from Shasun Pharmaceuticals, Puducherry. Avicel and 
magnesium stearate were purchased from Central Drug House (India). 
Acetone, diethyl ether and petroleum ether were from Qualigens (India) 
and sodium hydroxide from E-Merck (India). All the chemicals used 
were of analytical grade 
Methods 
Isolation of MAPMZ 
Three batches of MAPMZ was prepared on a laboratory scale by the 
method of Rao et al. [16]. 200 ml of cold distilled water was added to 20 
g of the seed powder and the slurry was prepared. Then the slurry was 
added to 800 ml of boiling water and boiled for another 20 min with 
continuous stirring. The solution was kept overnight to settle the solid 
matter. The clear solution was centrifuged for 20 min at 5000 rpm. The 
supernatant fluid was separated and twice the volume of acetone was 
added with continuous stirring. The formed precipitates were filtered 
and washed with petroleum ether and diethyl ether and then dried 
under vacuum at 50-60 °C. The dried materials were sieved through 
sieve No 80 and used for the formulation of tablets.  
Formulation of mucoadhesive tablets 
The mucoadhesive tablets (MAT) of pentoxifylline were prepared by 
using direct compression technique. Accurately weighed quantities of 
pentoxifylline, mucoadhesive polymer, avicel, magnesium stearate were 
mixed uniformly and this mixture was compressed into tablets by using 
Elite multi-station punching machine (Erweka) with 10 mm flat punches. 
The compression force was adjusted to give tablet hardness in the range 
of 7 to 11 kp. The constituent of the formulation is presented in table 1. 
Swelling study 
The formulated MAT’s were individually weighed (W1) and placed 
separately in an agar gel (2%) plates and incubated at 37±0.5 °C. The 
tablets were removed from petri dish at regular time intervals of 1 h 
up to 6 h and the excess water on the surface was removed carefully 
with filter paper. The swollen tablet was reweighed (W2) and the 
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Table 1: Formulation of mucoadhesive tablets of pentoxifylline 
Ingredients F1 F2 F3 
Pentoxifylline 400 400 400 
Avicel 152 122 92 
MAPMZ 30 60 90 
Magnesium stearate 18 18 18 
Total weight (mg) 600 600 600 
All the quantities are in mg 
 
Mucoadhesive strength 
The mucoadhesive strength (MS) of the formulated MAT’s was 
measured by using a modified 2-arm balance (fig. 1) with rabbit 
buccal mucosa[19]. The rabbit buccal mucosa was taken as the 
membrane and phosphate buffer (PB) pH 6.8 as moisturizing liquid. 
The rabbit buccal mucosa was obtained from the local 
slaughterhouse and stored in krebs buffer at 4 °C upon collection. 
The experiment was conducted within 3 h of the procurement of 
rabbit mucosa. The mucous layer was separated by using a surgical 
blade and washed with PB pH 6.8. It was then tied on a glass vial 
using a thread. This set was kept in a glass beaker, which was filled 
with PB pH 6.8 up to the surface of the buccal mucosa to maintain 
buccal mucosa viability. 
 
 
Fig. 1: Mucoadhesive strength measurement apparatus [19] 
 
The MAT was attached to the upper clamp of the apparatus and then 
the beaker was raised slowly until contact between rabbit buccal 
mucosa and MAT was established. A weight of 100 g was kept on the 
clamp for 5 min (pre-load time) to create a strong adhesion between 
rabbit buccal mucosa and the MAT. The weight (100 g) and pre-load 
time (5 min) were kept as constant for all the MAT’s. After the pre-
load time, the weight was removed from the clamp. Water was 
added at a rate of 60 drops/min into the beaker until the separation 
of rabbit buccal mucosa and MAT. The weight of water required to 
detach the MAT from buccal mucosa was noted as MS and the same 
was repeated with fresh mucosa (n = 6). The force of adhesion [20-
22] was calculated by using MS 




In vitro drug release studies 
The in vitro dissolution studies were carried out in a USP dissolution 
test apparatus (Electrolab, India) Type-II, by using 900 ml of 
phosphate buffer saline (PBS) pH 6.8. The dissolution test was 
carried out at a speed of 50 rpm and the temperature of 37±0.5 °C. 5 
ml of the samples were withdrawn at predetermined time intervals 
and assayed spectrophotometrically at 274 nm using Shimadzu UV 
spectrophotometer 1601. All the experiments were done thrice 
(n=3) and the standard curve specification was y=0.0392X (r2
Drug release kinetics 
 = 
0.9993, n = 10). 
The data obtained from in vitro release of drug was plotted in 
various kinetic models such as zero order (cumulative amount of 
drug released vs time), first order (log cumulative percentage of 
drug remaining vs time), and Higuchi’s model (cumulative 
percentage of drug released vs square root of time) to know the 
release kinetics [23–25]. 
Mechanism of drug release 
The mechanism of drug release of the prepared mucoadhesive tablet 
of pentoxifylline was calculated by using Korsmeyer equation (log 
cumulative percentage of drug released vs log time), and the 
exponent n was calculated through the slope of the straight line [26].  
Statistical analysis  
Each experiment was repeated at least three times. The results are 
expressed as the mean±SD One-way analysis of variance was used to 
test the statistical significance of differences among groups. 
Statistical significance of the differences of the means was 
determined by Student’s t-test. 
RESULTS AND DISCUSSION 
Natural polymers are preferred over synthetic and semi-synthetic 
polymers due to their low cost, non-toxic, emollient, free availability 
and non-irritating nature. Even though many polymers are available, a 
search for new polymers still interesting to get more efficacious 
polymers with less toxic. So in this present work, an attempt was made 
to study the mucoadhesive property of the natural polymer from the 
plant M. zapota by formulating pentoxifylline mucoadhesive tablets.  
The mucilage was isolated from the seeds of M. zapota by the 
method of Rao et al., [16]. The mucoadhesive tablets of 
pentoxifylline were formulated by using three different 
concentrations of MAPMZ. 
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The evaluation of tablets showed a satisfactory report on hardness 
(92.572±3.641 Neutons), friability (0.325±0.005%), weight 
variation (0.6106 mg±3.24%) and drug content (101.97±1.62%).  
An appropriate swelling index is mandatory for the uniform and 
sustained release of the drug and effective mucoadhesion [27]. The 
swelling study showed that the rate of swelling was indirectly 
proportional to the MAPMZ content of tablets. F1 batch (lower 
concentration of MAPMZ) had a high swelling index (4.292±0.10), 
and F3 the lowest (3.10±0.07) swelling index. Batch F2 and F3 didn’t 
show any significant change in their shape and form of tablets for a 
period of 6 h, when they kept in the agar gel (2%) plate. But the F1 
batch had completely changed the shape and form. 
MS of MAT’s of Manilkara zapota with rabbit buccal mucosa is 
shown in fig. 2. The mucoadhesion was occurred in three different 
stages: wetting, interpenetration, and mechanical interlocking 
between mucus and polymer. The MS is affected by various factors 
such as polymer’s molecular weight [28], swelling rate, contact time 
with mucus, and the biological membrane used for the study [29]. 
Tablets formulated with a high concentration of MAPMZ showed 
good MS in a contact time of 5 min. This high mucoadhesive strength 
of MAPMZ may be due to the formation of secondary bioadhesion 
bonds with mucin and interpenetration of the polymer chains in the 
interfacial region. However, the formulations F1, F2 and F3 
exhibited MS of 10.302±0.241, 33.752±0.246 and 36.762±0.134 gm, 
respectively, with rabbit buccal mucosa. 
  
 
Fig. 2: Mucoadhesive strength of tablets formulated with MAPMZ mean±SD, n=6 
 
The in vitro release studies (fig. 3) revealed that the release rate was 
indirectly proportional to the MAPMZ concentration. The F1 batch, 
which has a high swelling index, leads to more % of drug diffused 
from the polymer matrix [30]. The gradual decrease in the % of drug 
release from F1 (98.05±2.51) to F3 (60.16±2.64), in 5 h, may be due 
to the increase in the concentration of MAPMZ. It may be due to the 
in situ gelling property of MAP, which slows the dissolution rate of 
the drug pentoxifylline. Tablets of batch F2 and F3 were remaining 




Fig. 3: The cumulative release profile of mucoadhesive tablets of pentoxifylline formulated with MAPMZ mean±SD, n=3 
 
The zero order release described that the release rate is dose-
independent, which shows the cumulative amount of drug release vs 
time for zero-order kinetics. The first order release described the 
release rate is dose-dependent, which shows the log cumulative 
percent drug remaining vs time [31]. Higuchi’s model described the 
release of drugs from an insoluble matrix as a square root of a time-
dependent process based on Fickian diffusion. Higuchi square root 
kinetics, showing the cumulative percent drug release vs the square 
root of time[32]. The release constant was calculated from the slope 
of the appropriate plots, and the regression coefficient (r2) was 
determined (table 2). It was found that the in vitro drug release of 
mucoadhesive tablets of pentoxifylline was followed zero order 
release, as the plot showed the highest linearity (r2=0.9552, 0.9262 
and 0.9585 for the formulations, F1, F2 and F3 respectively), and 
Higuchi’s (r2=0.9916, 0.9845 and 0.99), which indicates the release 
rate independent. 
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Table 2: Release kinetics of mucoadhesive tablets of pentoxifylline 
Formulation First order Zero-order Higuchi Korsmeyer Peppas 
Slope r Slope 2 r Slope 2 r Slope 2 r2 
F1 0.3357 0.9186 19.891 0.9552 57.128 0.9916 0.8854 0.9716 
F2 0.1675 0.9205 9.2043 0.9262 38.352 0.9845 0.9163 0.9920 
F3 0.1594 0.8538 8.9379 0.9585 37.419 0.99 0.9887 0.991 
The corresponding Korsmeyer-Peppas [30] plot (log cumulative percent drug release vs time) indicated good linearity (r2
 
=0.9716, 0.992 and 0.991) 
and showed the matrix release pentoxifylline.  
CONCLUSION 
Reducing the frequency of the administration of the drug 
pentoxifylline will increase patient compliance and also reducing the 
dose-related side effects. The MAT’s formulated with MAPMZ 
controlled the release of pentoxifylline for 12 h; hence, the 
formulation may be considered as a once-daily sustained-release 
tablet of pentoxifylline. The in vitro dissolution studies indicated a 
sustained-release pattern of the drug pentoxifylline for 12 h of 
study. The results of this study revealed that increasing the 
concentration of the polymer leads to a decrease in the release rate 
and also increases the adhesion strength of the formulation. Drug 
release kinetics indicated that drug release was followed zero-order 
equation, as the plot showed the highest linearity.  
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